Nurx AI Visibility Market Strategy Report - STD Tests

Answer Capsule

Nurx holds 13.48% valid recommendation coverage in the October 2026 LLM Authority Index STD Tests benchmark, ranking fourth of ten tracked brands behind Everlywell, LetsGetChecked, and myLAB Box. The brand is visible but under-recommended relative to its presence: it appears in 27.30% of qualified observations but converts only about half of that presence into valid recommendation credit. Its clearest win is a category-leading net sentiment score of 0.6234 and a top-three rate that improved against the July 2026 baseline. Its clearest weakness is a 6.3-point coverage decline since baseline and a rank-one rate of just 1.42%. The clearest opportunity is converting its strong framing and improving top-three placement into first-position recommendations across the Brand Recommendation cluster.

Who This Report Is For

This report is for Nurx marketing, growth, and brand leaders, and for category analysts tracking how AI and search surfaces recommend telehealth and at-home testing brands at the decision moment.

Report Card

Executive Summary

Nurx is visible but under-recommended in the October 2026 STD Tests benchmark. The brand appeared in 77 of 282 qualified observations, a raw mention presence rate of 27.30%, but earned valid recommendation credit in only 38 of them, a valid recommendation coverage of 13.48%. That gap between being discussed and being shortlisted is the central finding of this report.

The framing around Nurx is the strongest in the category. Its net sentiment score of 0.6234 leads all ten tracked brands, ahead of LetsGetChecked at 0.5288 and Everlywell at 0.5115. Of its 77 mentions, 48 were positive, 29 neutral, and none negative. AI systems describe Nurx favorably when they describe it at all.

Placement is improving even as coverage declines. Nurx's top-three rate rose to 9.93% in October 2026 from 5.5% in July 2026, and its valid recommendation count rose to 38 from 29 in September 2026. When Nurx does enter a shortlist, it ranks higher than it did at baseline. Its average recommended rank of 2.78 sits behind Everlywell at 1.79 and LetsGetChecked at 2.18.

The weakness is first-position conversion. Nurx holds a rank-one rate of 1.42%, with 4 first-position placements against Everlywell's 44 and LetsGetChecked's 20. The brand is a frequent second or third option and rarely the answer.

The strongest platform signal is Perplexity, where Nurx holds a 33.33% valid recommendation coverage and a 27.78% top-three rate, both well above its category averages. The clearest platform gap is ChatGPT, where Nurx earned a single valid recommendation across 15 observations, a 6.67% coverage rate.

Coverage has fallen 6.3 points since the July 2026 baseline, from 19.8% to 13.5%, a decline the benchmark classifies as significant. The October 2026 reading did rise 4.3 points from September 2026, but the series trend remains below where Nurx started.

What Nurx Is Winning

Questions This Section Answers

• What is driving Nurx's category-leading sentiment score in STD Tests?
• Where has Nurx improved its recommendation placement since the July 2026 baseline?

Nurx holds the strongest framing quality in the category. Its net sentiment score of 0.6234 is the highest of the ten tracked brands, and it recorded zero negative mentions across 282 qualified observations. That is a meaningful asset in a category where AI systems are synthesizing health information and where cautionary framing is a real risk.

The brand also shows genuine placement improvement. Its top-three rate moved from 5.5% at the July 2026 baseline to 9.93% in October 2026, and its valid recommendation count rose from 29 in September 2026 to 38 in October 2026. Nurx is being placed higher within shortlists than it was three months earlier.

Perplexity is a narrow but real recommendation pocket. Nurx holds a 33.33% valid recommendation coverage and a 27.78% top-three rate on that platform, with 6 valid recommendations from 18 observations and a perfect 1.0 sentiment score on the mentions recorded. AI Overviews is a second area of relative strength, with a 15.52% coverage rate and a 0.9091 sentiment score.

These wins are real but limited. Nurx does not lead the category on coverage, top-three rate, rank-one rate, or average recommended rank. Its advantages are framing and momentum within shortlists, not category leadership.

Where Nurx Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Nurx rarely earn the first-position recommendation in STD Tests?
• Which platforms show the largest recommendation gap for Nurx compared to competitors?

The clearest gap is first-position conversion. Everlywell holds a rank-one rate of 15.60% and LetsGetChecked holds 7.09%, while Nurx holds 1.42%. When AI systems answer a brand recommendation prompt with a single named option, Nurx is rarely that option. The brand is present in the conversation but is not the answer.

The second gap is ChatGPT. Across 15 ChatGPT observations, Nurx earned 1 valid recommendation, a 6.67% coverage rate, and a single rank-one placement. By contrast, LetsGetChecked earned a 46.67% coverage rate on the same platform and myLAB Box earned 26.67%. ChatGPT is the platform where Nurx is most displaced by competitors.

The third gap is coverage erosion against baseline. Nurx fell 6.3 points from July 2026 to October 2026, a decline the benchmark classifies as significant. Everlywell, LetsGetChecked, and myLAB Box all declined against baseline as well, so this is partly a category-wide pattern, but Nurx also sits below all three on absolute coverage.

The fourth gap is scale relative to the leaders. Everlywell holds 88 valid recommendations and LetsGetChecked holds 77, against Nurx's 38. The top three brands in the category are separated by less than 5 points of coverage, while Nurx sits roughly 13 points behind the leader. The competitive set that matters most to Nurx is the group above it, not the group below.

Biggest Opportunity

The single clearest opportunity is converting Nurx's category-leading framing into first-position recommendations within the Brand Recommendation cluster. Nurx already earns positive framing at a higher rate than any competitor and already places inside the top three more often than it did at baseline. The missing step is being named first.

That conversion depends on the prompt and source layer rather than on general awareness. The benchmark's qualified observations all fall into the Brand Recommendation class, and the prompts driving them include at-home testing, discreet testing, and online prescriber legitimacy questions. Nurx's own domain appears in the top ten cited domains with 252 citations across five platforms, so the brand is already part of the public evidence layer. The opportunity is to make that evidence layer answer the first-position question more directly.

Competitive Landscape

Questions This Section Answers

• How does Nurx compare to Everlywell, LetsGetChecked, and myLAB Box on recommendation metrics?
• Which metric does Nurx lead in despite ranking fourth on coverage?

Everlywell holds the strongest recommendation-stage position in the STD Tests category, with LetsGetChecked and myLAB Box close behind. Nurx sits in a clear second tier, ahead of Labcorp OnDemand and the remaining tracked brands but well behind the top three on every recommendation metric.

Average recommended rank covers rank-eligible recommendations only.

Nurx ranks fourth on top-three rate and fourth on rank-one rate, and its average recommended rank of 2.78 is the fourth-best in the set. Its sentiment score is the highest in the table, which is the one column where it leads. The table shows a brand that is consistently placed but rarely placed first, and that is framed better than its position suggests.

AI Response Inconsistency Alerts

Questions This Section Answers

• What conflicting information did AI platforms provide about Nurx promo codes and insurance?
• Which sources are driving the discrepancy between ChatGPT and Perplexity on Nurx coupon eligibility?

One high-severity factual inconsistency was detected for Nurx, involving two AI platforms: ChatGPT and Perplexity.

AI platforms provided conflicting information about whether Nurx promo codes can be combined with insurance. When asked "Can I use a Nurx promo code with insurance?", ChatGPT stated that manufacturer coupons and copay cards can be used with private insurance, describing a process where a customer completes checkout with insurance and then messages Nurx about the coupon, citing the Nurx FAQ page on manufacturer coupons for birth control. Perplexity stated the opposite, that promo codes generally cannot be combined with insurance and are not valid if insurance is used on the same order, citing Groupon coupon pages, a third-party coupon aggregator, and a Nurx FAQ page on health insurance acceptance.

The two answers describe incompatible eligibility rules for the same question. The conflict is notable because the ChatGPT response drew on Nurx's own FAQ content while the Perplexity response drew primarily on third-party coupon aggregator pages. The source pattern suggests the discrepancy may originate in how coupon aggregator content frames promo code eligibility relative to Nurx's own published policy. This is a high-confidence conflict at 0.9 confidence, and it concerns a commercially sensitive topic where a prospective customer could receive contradictory guidance depending on which platform they ask.

Prompt Evidence

Perplexity / Brand Recommendation Prompt: "Which online doctors are legit?" Result: Nurx earned a valid recommendation with a top-three placement, part of its 33.33% Perplexity coverage rate, its strongest platform signal.

ChatGPT / Brand Recommendation Prompt: "Is there a rapid STD home test?" Result: Nurx did not earn a valid recommendation on ChatGPT, where it holds a single valid recommendation across 15 observations.

Gemini / Brand Recommendation Prompt: "How to discreetly test for STD?" Result: Nurx appeared with positive framing but earned no rank-one placement, consistent with its 0.0% rank-one rate on Gemini.

AI Overviews / Brand Recommendation Prompt: "at home std test" Result: Nurx earned a valid recommendation with a 0.9091 sentiment score on AI Overviews, one of its two strongest platforms.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map the specific prompts where Nurx is present but not recommended, and identify which competitors take the first-position slot when Nurx is displaced.

Phase 2: Recommendation Readiness Plan Prioritize the Brand Recommendation prompts where Nurx already earns top-three placement and build a plan to convert those placements into first-position answers.

Phase 3: Owned Answer Layer Buildout Strengthen Nurx's owned pages around the at-home testing, discreet testing, and online prescriber legitimacy questions that drive the qualified prompt set.

Phase 4: Citation / Authority Layer Development Address the coupon and insurance eligibility conflict by aligning Nurx's own FAQ content with the third-party coupon pages that AI systems are retrieving.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Nurx's coverage, top-three rate, rank-one rate, and sentiment month over month against Everlywell, LetsGetChecked, and myLAB Box.

Why This Matters

AI presence alone is not enough. Nurx is mentioned in more than a quarter of qualified observations and is framed better than any competitor, yet it converts only about half of that presence into recommendation credit and rarely earns the first-position answer. In a category where buyers ask AI systems which testing option to choose, being discussed favorably is not the same as being chosen.

The next move is targeted correction of the prompt, page, and citation layers. That means closing the ChatGPT gap, resolving the promo code and insurance conflict that is producing contradictory answers across platforms, and building the owned and third-party evidence that AI systems retrieve when they form a first-position recommendation. The benchmark shows where Nurx stands. The work is in the layers that determine where it lands next.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Nurx in October 2026: (48 × 1 + 29 × 0 + 0 × -1) / 77 = 0.6234.

This matters because unclassified mention counts are misleading. A brand can appear frequently in AI answers and still lose the buyer decision if most of those appearances are neutral references, cautionary framing, or mentions inside a competitor comparison. Share of voice is a diagnostic metric, not a business KPI.

A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Nurx's 77 mentions include 29 neutral references that carry no recommendation weight, and its 38 valid recommendations are the number that actually reflects shortlist eligibility. Classified sentiment is required before interpreting AI visibility, and for Nurx the classified picture is favorable: strong positive framing, no negative mentions, and a real gap between being mentioned and being recommended.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Nurx's AI recommendation position in the STD Tests category for October 2026. It is not a client result and does not describe work performed by CiteWorks Studio.
2. The reporting window is October 2026, with the July 2026 measurement as the series baseline and September 2026 as the prior month.
3. Six AI and search surfaces were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six produced at least one qualified observation in October 2026.
4. The October 2026 run began with 800 source prompt-surface observations and 583 unique questions after de-duplication. Of those, 437 were relevant to the STD Tests category and 363 were irrelevant.
5. The public denominator is 282 qualified observations, the set that survived both qualification stages. Brand-level percentages use this denominator, not the raw collection.
6. Ten brands were tracked: Nurx, Everlywell, LetsGetChecked, myLAB Box, Labcorp OnDemand, QuestDirect, STDcheck.com, plushcare, Priority STD Testing, and Health Testing Centers.
7. The qualified observations fell entirely into the Brand Recommendation cluster. The Pricing & Value and Multi-Brand Comparison clusters carried no qualified data in this measurement period, so the benchmark cannot answer which brand wins on cost or in direct head-to-head comparison.
8. A mention is any appearance of the brand in a qualified observation, regardless of recommendation status. A valid recommendation is an observation where the brand appears in a valid recommendation shortlist. These are separate metrics and are reported separately throughout this report.
9. Top-three rate measures how often a brand ranks within the top three recommendations. Rank-one rate measures how often it is the first recommendation. Average recommended rank covers rank-eligible recommendations only.
10. Net sentiment score is calculated as (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions. It reflects framing quality, not customer sentiment.
11. The benchmark's public percentages cannot identify the specific prompts, competitors, or sources driving each brand's result. Company-level analysis is required to explain why a brand lands where it does.
12. Two taxonomy notes apply. The cluster labels carried in the underlying data reference a different vertical than the STD Tests category studied here, so cluster-level interpretation is limited to the Brand Recommendation class. The records for plushcare and PlushCare appear as separate entries in the October 2026 data, and cross-month comparisons for those names should account for that.

See How AI Is Recommending Your Brand

The public benchmark shows where Nurx stands in the STD Tests category. A company-level AI visibility audit shows why, mapping the specific prompts, competitors, platforms, and source pages that shape how AI systems recommend Nurx and where competitors are being named instead.